Opko Health (OPK) Non-Current Deferred Tax Liability (2014 - 2026)
Opko Health (OPK) reported Non-Current Deferred Tax Liability of $114.6 million for Q1 2026, down 11.49% on a YoY basis from $129.4 million in Q1 2025, and down 9.25% quarter-over-quarter from $126.2 million in Q4 2025.
Opko Health (OPK) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Opko Health has reported Non-Current Deferred Tax Liability for 13 years, with the latest figure at $114.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 11.49% year-over-year to $114.6 million; the trailing twelve-month figure through Mar 2026 stood at $114.6 million (down 11.49% YoY), and the FY2025 full-year result was $126.2 million, down 10.34% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $114.6 million, down from $126.2 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $176.7 million in Q2 2022, with the low at $113.3 million in Q2 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $130.3 million across 5 years, with a median of $128.4 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability grew 29.56% — and 2023, when it dropped 24.72%.
- Opko Health's Non-Current Deferred Tax Liability stood at $126.4 million in 2022, then rose by 0.27% to $126.8 million in 2023, then rose by 11.06% to $140.8 million in 2024, then decreased by 10.34% to $126.2 million in 2025, then slipped by 9.25% to $114.6 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $114.6 million (Q1 2026), $126.2 million (Q4 2025), and $130.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.56 Mn |
| Mar 31, 2026 | 114.56 Mn |
| Dec 31, 2025 | 126.24 Mn |
| Dec 31, 2025 | 126.24 Mn |
| Sep 30, 2025 | 130.34 Mn |
| Sep 30, 2025 | 130.34 Mn |
| Jun 30, 2025 | 113.33 Mn |
| Jun 30, 2025 | 113.33 Mn |
| Mar 31, 2025 | 129.44 Mn |
| Mar 31, 2025 | 129.44 Mn |
| Dec 31, 2024 | 140.80 Mn |
| Dec 31, 2024 | 140.80 Mn |
| Sep 30, 2024 | 128.41 Mn |
| Sep 30, 2024 | 128.41 Mn |
| Jun 30, 2024 | 119.12 Mn |
| Jun 30, 2024 | 119.12 Mn |
| Mar 31, 2024 | 121.64 Mn |
| Mar 31, 2024 | 121.64 Mn |
| Dec 31, 2023 | 126.77 Mn |
| Dec 31, 2023 | 126.77 Mn |